Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
08/2007
08/02/2007US20070179165 Cyclic compounds
08/02/2007US20070179122 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
08/02/2007CA2640031A1 Novel method for synthesis of 1,4-morpholine-2,5-diones
08/01/2007EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy
08/01/2007EP1812425A2 C-fms kinase inhibitors
08/01/2007EP1812008A1 Il-8 receptor antagonists
08/01/2007EP1187592B1 Alpha v integrin receptor antagonists
08/01/2007CN101010307A Synthesis of a benzoxazinone
08/01/2007CN101010306A Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives
07/2007
07/31/2007US7250415 1,1-Disubstitutedcycloalkyl-, glycinamidyl-, sulfonyl-amidino-, and tetrahydropyrimidinyl-containing diaminoalkyl, β-aminoacids, α-aminoacids and derivatives thereof as factor Xa inhibitors
07/31/2007US7250412 Diisopropylphenyl esters of N-amino- or N-heterocyclyl-alkanamic acids, e.g., N-(2-Piperidin-1-yl-ethyl)-succinamic acid 2,6-diisopropylphenyl ester; induction and maintenance of anesthesia or sedation
07/31/2007CA2069145C Assay method utilizing induced luminescence
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/25/2007EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
07/25/2007CN101006084A 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247625 treatment of uterine fibroids, endometriosis, dysmenorrhea, breast cancer, uterine caner, ovarian cancer, prostate cancer, and meningioma; hormone replacement therapy, including perimenopausal, menopausal, and post-menopausal hormone replacement therapy; and in the treatment of skin disorders
07/19/2007US20070167623 antagonists of NK2 receptors of neurokinin A; the N-protected 2-vinyl-2-dihalophenylmorpholine intermediates from cyclization of 1-Chloro-2-(3,4-difluorophenyl)but-3-en-2-ol prepared from 1-[Benzyl(2-hydroxyethyl)amino]-2-(3,4-difluoro-phenyl)but-3-en-2-ol and an aminoethanol; industrial scale
07/19/2007US20070167444 Benzamide derivative or salt thereof
07/18/2007EP1807406A2 Inhibitors of c-fms kinase
07/18/2007EP1807078A1 Diaminoalkane aspartic protease inhibitors
07/18/2007EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
07/18/2007CN1326844C 2H-3,1-benzo oxole heterocyclic compound hynthesizing method
07/17/2007US7245073 Quinoxaline derivatives, and light emitting element using thereof
07/17/2007US7244776 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/17/2007US7244728 Long acting betamimetics for the treatment of respiratory diseases
07/12/2007WO2007077228A1 Process for preparing a benzoxazinone
07/12/2007WO2006058201A3 Heterocyclic and bicyclic compounds, compositions and methods
07/12/2007US20070161631 Substituted Phenoxyacetic Acids
07/12/2007US20070161623 Urea derivatives
07/11/2007EP1806345A1 Process for preparing a benzoxazinone
07/11/2007EP1805170A1 Mif-inhibitors
07/11/2007CN1325480C Novel phenylalanine derivatives
07/10/2007US7241759 Cholecystokinin receptors as modulators to mediate diseases and gastrointestinal disorders
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/05/2007WO2007075387A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
07/05/2007WO2007058583A3 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
07/05/2007US20070155964 Naphthols useful for preparing indeno-fused photochromic naphthopyrans
07/05/2007US20070155741 R-6-Hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino ]-ethyl}-4H-benzo[1,4]oxazin-3-one, or an acid addition salt thereof; betamimetics; for administration once a day for treating COPD
07/05/2007US20070155736 Fluorinated phno and analogues thereof
07/05/2007DE102005063192A1 Racematspaltung von 2,6-trans-Dimethyl-morpholin Resolution of racemic 2,6-trans-dimethyl-morpholine
07/05/2007CA2633958A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners
07/04/2007EP1802595A1 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
07/04/2007EP1621566B1 Fluxing no-flow underfill composition containing benzoxazines
07/03/2007US7238789 Sulfonated [8,9] benzophenoxazine dyes and the use of their labelled conjugates
07/03/2007US7238710 A piperidin-2-one, 1,3-oxazinan-2-one, or 1,3-thiazinan-2-one compound for treatment of glaucoma, mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts; 7-{(4S)-4-[(3R)-3-hydroxy-4-phenylbutyl]-2-oxo-1,3-oxazinan-3-yl}heptanoic acid; side effect reduction
06/2007
06/28/2007US20070149517 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (vri) activity
06/28/2007US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof
06/27/2007EP1801108A1 Morpholine compound
06/27/2007EP1283829B1 Method for making acylamides by synthesizing and acylating benzoxazines
06/27/2007EP1280784B1 Biologically active 4h-benzo 1,4|oxazin-3-ones
06/27/2007CN1989141A Bicyclic heterocycles as HIV integrase inhibitors
06/27/2007CN1989100A Therapeutic compounds
06/26/2007US7235550 Polycyclic azaindole compounds
06/21/2007WO2007070760A2 Compounds which modulate the cb2 receptor
06/21/2007US20070142379 Cyclohexyl derivatives as selective estrogen receptor modulators
06/21/2007US20070142229 Agriculture
06/21/2007CA2632030A1 Compounds which modulate the cb2 receptor
06/20/2007EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
06/20/2007EP1797051A1 Benzoxazine and quinoxaline derivatives and uses
06/20/2007CN1984895A Synthesis and uses of synephrine derivatives
06/20/2007CN1984681A Agent for promoting the recovery from dysfunction after the onset of central neurological disease
06/20/2007CN1982299A Benzoxasine and benzothiasine derivatives and pharmaceutical composition containing the same
06/20/2007CN1982298A Hydro diamine compound, its production and use and composition containing it
06/19/2007US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
06/14/2007WO2007065828A1 Glucocorticoid receptor modulators as antiinflammatory agents
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007US20070135434 Sulfonyloxy derivatives
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007CA2632109A1 Glucocorticoid receptor modulators as antiinflammatory agents
06/13/2007EP1794136A1 Aryl-ureido benzoxazinone compounds
06/13/2007CN1321121C Post processing method for preparing levo-ofloxacin
06/13/2007CN1321120C Phenoxazones, preparing process and pharmaceutical uses thereof
06/12/2007US7229992 Process for the preparation of a piperazine derivative
06/12/2007US7229989 When used in photochromic eyeglass lenses, produce essentially blue color tones which have a high darkening capacity
06/12/2007US7229986 Melanin-concentrating hormone antagonist
06/12/2007US7229842 Metal chelate containing compositions for use in chemiluminescent assays
06/12/2007US7229803 Reaction of (di)amines in the presence of a lysine oxidase and of a reducing agent
06/07/2007WO2007064316A1 Bicyclic heterocycles as hiv integrase inhibitors
06/07/2007WO2007063950A1 Long-wave fluorescent substance for diagnosis or treatment of conformation disease and use thereof
06/07/2007WO2007063925A1 2-aminobenzamide derivative
06/07/2007WO2007037898A3 Theramutein modulators
06/07/2007WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof
06/07/2007WO2006062898A3 Compounds and methods for treating hemorrhagic fever viruses
06/07/2007US20070129509 Curable compositions
06/07/2007CA2629964A1 2-aminobenzamide derivative
06/06/2007EP1791809A1 Substituted aniline derivatives
06/06/2007CN1976909A New isobenzoxazinones and their use as ultraviolet light absorbers
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007US7226918 DNA-PK inhibitors
06/05/2007CA2293836C Polymorphic form of a tachykinin receptor antagonist
05/2007
05/31/2007WO2007041077A3 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
05/31/2007WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same
05/31/2007WO2007024836A3 Preparation of tetrahydro-1,8-dioxa-4a-aza-naphthalenes and their use in coating applications
05/31/2007WO2006113552A3 Cyanoarylamines
05/31/2007WO2005099688A3 Cyclic compounds
05/31/2007US20070123533 New process for preparing an optically pure 2-morpholinol derivative
05/30/2007EP1789405A1 Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
05/30/2007EP1789404A2 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 112